Abstract
Diabetes mellitus is a life-threatening chronic metabolic disease caused by lack of insulin and/or insulin dysfunction, characterized by high levels of glucose in the blood (hyperglycemia). Millions worldwide suffer from diabetes and its complications. Significantly, it has been recognized that type 2 diabetes is an important preventable disease and can be avoided or delayed by lifestyle intervention. Presently, there are many chemical and biochemical hypoglycemic agents (synthetic drugs), that are used in treating diabetes and are effective in controlling hyperglycemia. However, as they may have harmful side-effects and fail to significantly alter the course of diabetic complications, natural anti-diabetic drugs from medicinal plants have attracted a great deal of attention. Medicinal mushrooms have been valued as a traditional source of natural bioactive compounds over many centuries and have been targeted as potential hypoglycemic and anti-diabetic agents. Bioactive metabolites including polysaccharides, proteins, dietary fibres, and many other biomolecules isolated from medicinal mushrooms and their cultured mycelia have been shown to be successful in diabetes treatment as biological anti-hyperglycemic agents. In this review we discuss the biological nature of diabetes and, in particular, explore some promising mushrooms that have experimental anti-diabetic properties, preventing or reducing the development of diabetes mellitus. The importance of medicinal mushrooms as agents of medical nutrition therapy and how their metabolites can be used as supportive candidates for prevention and control of diabetes is explored. Future prospects for this field of study and the difficulties and constraints that might affect the development of rational drug products from medicinal mushrooms are discussed.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Abdullah N, Ismail S, Aminudin N, Shuib AS, Lau BF (2012) evaluation of selected culinary-medicinal mushrooms for antioxidant and ACE inhibitory activities. Evid Based Complement Alternat Med 464238:12 p. doi:10.1155/2012/464238
Abraham WR (2001) Bioactive Sesquiterpenes produced by fungi: are they useful for humans as well? Curr Med Chem 8:583–606
Adachi H, Fujiwara Y, Ishii N (1998) Effects of oxygen on protein carbonyl and aging in Caenorhabditis elegans mutants with long (age-1) and short (mev-1) life spans. J Gerontol 53:B240–B244
Adotey G, Quarcoo A, Holliday JC, Fofie S, Saaka B (2011) Effect of immunomodulating and antiviral agent of medicinal mushrooms (Immune Assist 24/7TM) on CD4+ T-lymphocyte counts of HIV-infected patients. Int J Med Mushr 13:109–113
Agardh CD, Stenram U, Torffvit O, Agardh E (2002) Effects of inhibition of glycation and oxidative stress on the development of diabetic nephropathy in rats. J Diabetes Complicat 16:395–400
Agarwal S, Sohal RS (1993) Relationship between aging and susceptibility to protein oxidative damage. Biochem Bioph Res Comm 194:1203–1206
Agrawal RP, Chopra A, Lavekar GS, Padhi MM, Srikanth N, Ota S, Jain S (2010) Effect of oyster mushroom on glycemia, lipid profile and quality of life in type 2 diabetic patients. Australian J Med Herbalism 22:50–54
Ajith TA, Janardhanan KK (2007) Indian medicinal mushrooms as a source of antioxidant and antitumor agents. J Clin Biochem Nutr 40:157–162
Aksenova MV, Aksenov MY, Carney JM, Butterfield DA (1998) Protein oxidation and enzyme activity decline in old brown Norway rats are reduced by dietary restriction. Mech Ageing and Develop 100:157–168
Alarcón J, Aguila S, Arancibia-Avila P, Fuentes O, Zamorano-Ponce E, Hernández M (2003) Production and purification of statins from Pleurotus ostreatus (Basidiomycetes) strains. Z Naturforsch C 58:62–64
Alexandre J, Kahatt C, Cvitkovic FB, Faivre S, Shibata S et al (2007) A phase I and pharmacokinetic study of irofulven and capecitabine administered every 2 weeks in patients with advanced solid tumors. Invest New Drug 25:453–462
Aly AH, Debbab A, Kjer J, Proksch P (2010) Fungal endophytes from higher plants: a prolific source of phytochemicals and other bioactive natural products. Fungal Divers 41:1–16
American Diabetes Association (2008) Economic costs of diabetes in the U.S. in 2007. Diabetes Care 31:596–615
American Diabetes Association (2011) Standards of medical care in diabetes - 2011. Diabetes Care 34:S11–S61
Anderson JW, Baird P, Davis RH Jr, Ferreri S, Knudtson M, Koraym A, Waters V, Williams CL (2009) Health benefits of dietary fiber. Nutr Rev 67(4):188–205
Andújar-Plata P, Pi-Sunyer X, Laferrère B (2012) Metformin effects revisited. Diabetes Res Clin Pract 95:1–9
Anon (2008) Canadian Diabetes Association 2008 clinical practice guidelines for the prevention and management of diabetes in Canada. Canadian J Diabetes 32:S1–S201
Anon (2009) A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med 360:2503–2515
Anon (2010) Position of the American Dietetic Association: integration of medical nutrition therapy and pharmacotherapy. J Am Diet Assoc 110:950–956
Anon (2011) Total Health Life 2005. “High Blood Sugar”.Total Health Institute http://www.totalhealthlife.com/about.html
Arathuzik GG, Goebel-Fabbri AE (2011) Nutrition therapy and the management of obesity and diabetes: an update. Curr Diab Rep 11:106–110
Asbun J, Villarreal FJ (2006) The pathogenesis of myocardial fibrosis in the setting of diabetic cardiomyopathy. J Am Coll Cardiol 47:693–700
Avogaro A (2012) Treating diabetes today with gliclazide MR: a matter of numbers. Diabetes Obes Metab 14:14–19
Ayaz FA, Chuang LT, Torun H, Colak A, Sesli E, Presley J (2011) Fatty acid and amino acid compositions of selected wild-edible mushrooms consumed in Turkey. Int J Food Sci Nutr 629:328–335
Badole SL, Bodhankar SL (2007) Interaction of aqueous extract of Pleurotus pulmonarius (Fr.) Quel.-Champ with acarbose in alloxan induced diabetic mice. J Appl Biomed 5:157–166
Badole SL, Shah SN, Patel NM, Thakurdesai PA, Bodhankar SL (2006) Hypoglycemic activity of aqueous extract of Pleurotus pulmonarius in alloxan-induced diabetic mice. Pharm Biol 44:421–425
Balon TW, Jasman AP, Zhu JS (2002) A fermentation product of Cordyceps sinensis increases whole-body insulin sensitivity in rats. J Altern Complem Med 8:315–323
Bao X, Duan J, Fang X, Fang J (2001) Chemical modifications of the (1→3)-α-D-glucan from spores of Ganoderma lucidum and investigation of their physicochemical properties and immunological activity. Carbohyd Res 336:127–140
Barra NG, Chew MV, Holloway AC, Ashkar AA (2012) Interleukin-15 treatment improves glucose homeostasis and insulin sensitivity in obese mice. Diabetes Obes Metab 14:190–193
Bastami MS, Bohari SPM, Har WM, Wahab MN, Rahmani AS et al (2007) Hypoglycemic, insulinotrophic and cytotoxic activity of three species of Ganoderma. Malaysian J Sci 26(2):41–46
Bazzano LA, Li TY, Joshipura KJ, Hu FB (2008) Intake of fruit, vegetables, and fruit juices and risk of diabetes in women. Diabetes Care 31:1311–1317
Beck-Nielsen H, Henriksen JE, Vaag A, Hother-Nielsen OH (1995) Pathophysiology of non-insulin-dependent diabetes mellitus (NIDDM). Diabetes Res Clin Pr 28:13–25
Beluhan S, Ranogajec A (2011) Chemical composition and non-volatile components of Croatian wild edible mushrooms. Food Chem 124:1076–1082
Ben-Haroush A, Yogev Y, Hod M (2004) Epidemiology of gestational diabetes mellitus and its association with Type 2 diabetes. Diabetes Med 21:103–113
Bisbal C, Lambert K, Avignon A (2010) Antioxidants and glucose metabolism disorders. Curr Opin Clin Nutr Metab Care 13:439–446
Boonyanuphap J, Hansawasdi C (2010) Spatial distribution of β-glucan containing wild mushroom communities in subtropical dry forest, Thailand. Fungal Divers 46:29–42
Brennan MA, Derbyshire E, Tiwari BK, Brennan CS (2012) Enrichment of extruded snack products with coproducts from chestnut mushroom (Agrocybe aegerita) production: interactions between dietary fiber, physicochemical characteristics, and glycemic load. J Agric Food Chem 60:4396–4401
Brun JF, Traverso M, Fédou C, Renard E, Mercier J (2009) Reassessing two myths about exercise in type-1 diabetics: The hyperglycemic threshold at 250 mg/dL counter-indicating exercise and the “glucose pulse”. Science & Sports 24:108–110
Brun JF, Marti B, Fédou C, Farré A, Renard E, Mercier J (2012) Two parameters statistically explain blood glucose decrease during exercise at steady state in type 1 diabetics: pre-exercise blood glucose and insulinemia. Science & Sports 27:111–114
Cangeri Di Naso F, Noronha de Mello R, Bona S, Dias AS, Porawski M, de Barros Balcao Ferraz A, Richter MF, Possa Marroni N (2010) Effect of Agaricus blazei Murill on the pulmonary tissue of animals with streptozotocin-induced diabetes. Exp Diabetes Res Article ID 543926, 8 p. doi:10.1155/2010/543926
Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC (2001) Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke 32:2426–2432
CDC Centers for Disease Control and Prevention (2011) Diabetes successes and opportunities for population-based prevention and control; at a glance 2011. http://www.cdc.gov/chronicdisease/resources/publications/aag/ddt.htm
Cha JY, Jun BS, Kim JW, Park SH, Lee CH, Cho YS (2006) Hypoglycemic effects of fermented Chaga mushroom (Inonotus obliquus) in the diabetic Otsuka Long-Evans Tokushima Fatty (OLETF) rat. Food Sci Biotechnol 15:739–745
Chandra M, Chandra N, Agrawal R, Kumar A, Ghatak A, Pandey VC (1994) The free radical system in ischemic heart disease. Int J Cardiol 43:121–125
Chang ST (1999) Global impact of edible and medicinal mushrooms on human welfare in the 21st century: nongreen revolution. Int J Med Mushr 1:1–8
Chang ST, Mshigeni KE (2000) Ganoderma lucidum-Paramount among medicinal mushrooms. Discov Innov 12:97–101
Chaufan C, Davis M, Constantino S (2011) The twin epidemics of poverty and diabetes: understanding diabetes disparities in a low-income Latino and immigrant neighborhood. J Commun Health 36:1032–1043
Chen SJ, Jin SY (1992) Summary of research of hosts of Cordyceps sinensis in China. Shizhen Guoyao Yanju 3:37–39
Chen J, Seviour R (2007) Medicinal importance of fungal β-(1→3), (1→6)-glucans. Mycol Res 111:635–652
Chen H, Lu X, Qu Z, Wang Z, Zhang L (2010) Glycosidase inhibitory activity and antioxidant properties of a polysaccharide from mushroom Inonotus obliquus. J Food Biochem 34:178–191
Chen G, Luo YC, Ji BP, Li B, Su W, Xiao ZL, Zhang GZ (2011) Hypocholesterolemic effects of Auricularia auricula ethanol extract in ICR mice fed a cholesterol-enriched diet. J Food Sci Technol-Mysore 48:692–698
Chen J, Mao D, Yong Y, Li J, Wei H, Lu L (2012) Hepatoprotective and hypolipidemic effects of water-soluble polysaccharidic extract of Pleurotus eryngii. Food Chem 130:687–694
Cheng AYY, Fantus IG (2005) Oral antihyperglycemic therapy for type 2 diabetes mellitus. Can Med Assoc J 172:213–226
Cheng CR, Yue QX, Wu ZY, Song XY, Tao SJ, Wu XH, Xu PP, Liu X, Guan SH, Guo DA (2010) Cytotoxic triterpenoids from Ganoderma lucidum. Phytochem 71:1579–1585
Cheng YW, Chen YI, Tzeng CY, Chen HC, Tsai CC, Lee YC, Lin JG, Lai YK, Chang SL (2012a) Extracts of Cordyceps militaris lower blood glucose via the stimulation of cholinergic activation and insulin secretion in normal rats. Phytother Res (Published Online). doi:10.1002/ptr.3709
Cheng M, Li BY, Li XL, Wang Q, Zhang JH, Jing XJ, Gao HQ (2012b) Correlation between serum lactadherin and pulse wave velocity and cardiovascular risk factors in elderly patients with type 2 diabetes mellitus. Diabetes Res Clin Pract 95:125–131
Cheung PC (2008) Mushrooms as functional food. John Wiley and Sons, New Jersey
Chinner S, Scherbaum WA, Bornstein SR, Barthel A (2005) Molecular mechanisms of insulin resistance. Diabetic Med 22:674–682
Cho EJ, Hwang HJ, Kim SW, Oh JY, Baek YM, Choi JW, Bae SH, Won J, Yun JW (2007) Hypoglycemic effects of exopolysaccharides produced by mycelial cultures of two different mushrooms Tremella fuciformis and Phellinus baumii in ob/ob mice. Appl Microbiol Biotechnol 75:1257–1265
Choi HK, Willett WC, Stampfer MJ, Rimm E, Hu FB (2005) Dairy consumption and risk of type 2 diabetes mellitus in men: a prospective study. Arch of Int Med 165:997–1003
Choi D, Kim YS, Nam HG, Shin HJ, Soon-Na M, Choi OY, Lee HD, Cha WS (2011) Functional properties of hot water extract of a fish, seaweed, and mushroom mixture. Korean J Chem Eng 28:1266–1271. doi:10.1007/s11814-011-0049-x
Chorváthová V, Bobek P, Ginter E, Klvanová J (1993) Effect of the oyster fungus on glycaemia and cholesterolaemia in rats with insulin-dependent diabetes. Physiol Res 42:175–179
Chung MJ, Chung CK, Jeong Y, Ham SS (2010) Anti-cancer activity of subfractions containing pure compounds of Chaga mushroom (Inonotus obliquus) extract in human cancer cells and in Balbc/c mice bearing Sarcoma-180 cells. Nutr Res Pract 4:177–182
Cobelli C, Renard E, Kovatchev B (2011) Artificial pancreas past, present, future. Diabetes 60:2672–2682
Colagiuri S (2012) Optimal management of type 2 diabetes: the evidence. Diabetes Obes Metab 14:3–8
Colak A, Faiz O, Sesli E (2009) Nutritional composition of some wild edible mushrooms. Turkish J Biochem 34:25–31
Costa B, Cabré JJ, Sagarra R, Solà-Morales O, Barrio F, Piñol JL, Cos X, Bolíbar B, Castell C, Kissimova-Skarbek K, Tuomilehto J (2011) Rationale and design of the PREDICE project: cost-effectiveness of type 2 diabetes prevention among high-risk Spanish individuals following lifestyle intervention in real-life primary care setting. BMC Publ Health 11:623–630
Crichton GE, Elias MF, Dore GA, Robbins MA (2012) Relation between dairy food intake and cognitive function: the Maine-Syracuse Longitudinal Study. Int Dairy J 22:15–23
Cui B, Han L, Qu J, Lv Y (2009) Hypoglycemic activity of Grifola frondosa rich in vanadium. Biol Trace Elem Res 131:186–191
Curll M, DiNardo M, Noschese M, Korytkowski MT (2010) Menu selection, glycaemic control and satisfaction with standard and patient-controlled consistent carbohydrate meal plans in hospitalised patients with diabetes. Qual Saf Health Care 19:355–359
Da Silva MCS, Naozuka J, da Luz JMR, de Assunção LS, Oliveira PV, Vanetti MCD, Bazzolli DMS, Kasuya MCM (2012) Enrichment of Pleurotus ostreatus mushrooms with selenium in coffee husks. Food Chem 131:558–563
Dai YC (2010) Hymenochaetaceae (Basidiomycota) in China. Fungal Divers 45:131–343
Dai YC, Zhou LW, Cui BK, Chen YQ, Decock C (2010) Current advances in Phellinus sensu lato: medicinal species, functions, metabolites and mechanisms. Appl Microbiol Biotechnol 87(5):1587–1593
Das SK, Masuda M, Sakurai A, Sakakibara M (2010) Medicinal uses of the mushroom Cordyceps militaris: current state and prospects. Fitoterapia 81:961–968
Davis TM, Knuiman M, Kendall P, Vu H, Davis WA (2000) Reduced pulmonary function and its associations in type 2 diabetes: the Fremantle Diabetes Study. Diabetes Res Clin Pract 50:153–159
De Mello VD, Schwab U, Kolehmainen M, Koenig W, Siloaho M, Poutanen K, Mykkänen H, Uusitupa M (2011) A diet high in fatty fish, bilberries and wholegrain products improves markers of endothelial function and inflammation in individuals with impaired glucose metabolism in a randomised controlled trial: the Sysdimet study. Diabetologia 54:2755–2767
De Silva DD, Rapior S, Fons F, Bahkali AH, Hyde KD (2012) Medicinal mushrooms in supportive cancer therapies: an approach to anti-cancer effects and putative mechanisms of action - A Review. Fungal Divers 55:1–35
Deepalakshmi K, Mirunalini S (2011) Therapeutic properties and current medical usage of mushroom: Ganoderma lucidum. Int J Pharmaceutical Sci Res 2:1922–1929
Ding ZY, Lu YJ, Lu ZX, lv FX, Wang YH, Bei XM, Wang F, Zhang KC (2010) Hypoglycaemic effect of comatin, an antidiabetic substance separated from Coprinus comatus broth, on alloxan-induced-diabetic rats. Food Chem 121:39–43
Ding Z, Wang W, Wang F, Wang Q, Zhang K (2012) Polysaccharides production by submerged fermentation of Coprinus comatus and their inhibitory effects on non-enzymatic glycosylation. J Med Plants Res 6:1375–1381
Dodd H, Williams S, Brown R, Venn B (2011) Calculating meal glycemic index by using measured and published food values compared with directly measured meal glycemic index. Am J Clin Nutr 94(4):992–996
Dong JY, Zhang YH, Tong K, Quin LQ (2012) Depression and risk of stroke: a meta-analysis of prospective studies. Stroke 43:32–37
Dotan N, Wasser SP, Mahajna J (2011) The culinary-medicinal mushroom Coprinus comatus as a natural antiandrogenic modulator. Integr Cancer Ther 10:148–159
El-Rahim AHA, Radwan HA, El-Moneim OMA, Farag IM, Nada SA (2010) The influence of amaryl on genetic alterations and sperm abnormalities of rats with alloxan-induced hyperglycemia. J American Sci 6:1739–1748
Eurich DT, McAlister FA, Blackburn DF, Majumdar SR, Tsuyuki RT, Varney J, Johnson JA (2007) Benefits and harms of antidiabetic agents in patients with diabetes and heart failure: systematic review. British Medical Journal (BMJ) 335:497
Farret A, Catargi B, Riveline JP, Melki V, Schaepelynck P, Sola A, Guerci B, Bertet H, Mura T, Chevassus H, Renard E (2012) Controlled randomized sudy in cross-over comparing the effects on glycemic control of immediate and combined bolus in type 1 diabetic patients treated by portable insulin pump. Diabetes and Metabolism 38(Special Issue: 2):A6–A6
Fatmawati S, Shimizu K, Kondo R (2011) Ganoderol B: a potent α-glucosidase inhibitor isolated from the fruiting body of Ganoderma lucidum. Phytomedicine 18:1053–1055
Feillet-Coudray C, Rock E, Coudray C, Grzelkowska K, Azais-Braesco V, Dardevet D, Mazur A (1999) Lipid peroxidation and antioxidant status in experimental diabetes. Clin Chim Acta 284:31–43
Fernández-Real JM, Pickup JC (2012) Innate immunity, insulin resistance and type 2 diabetes. Diabetologia 55:273–278
Fernández-Real JM, Ricart W (1999) Insulin resistance and inflammation in an evolutionary perspective. The contribution of cytokine genotype/phenotype to thriftiness. Diabetologia 42:1367–1374
Ferreira ICFR, Vaz JA, Vasconcelos MH, Martins A (2010) Compounds from wild mushrooms with antitumor potential. Anticancer Agents Med Chem 10:424–436
Firenzuoli F, Gori L, Lombardo G (2008) The medicinal mushroom Agaricus blazei murrill: review of literature and pharmaco-toxicological problems. Evid Based Complement Alternat Med 5:3–15
Fortes RC, Carvalho Garbi Novaes MR (2011) The effects of Agaricus sylvaticus fungi dietary supplementation on the metabolism and blood pressure of patients with colorectal cancer during post surgical phase. Nutr Hosp 26:176–186
Fortes RC, Recôva VL, Melo AL, Novaes MRCG (2008) Effects of dietary supplementation with medicinal fungus in fasting glycemia levels of patients with colorectal cancer: a randomized, double-blind, placebo-controlled clinical study. Nutr Hosp 23:591–598
Fortes RC, Novaes MR, Recôva VL, Melo AL (2009) Immunological, hematological, and glycemia effects of dietary supplementation with Agaricus sylvaticus on patients' colorectal cancer. Exp Biol Med (Maywood) 234:53–62
Francia C, Fons F, Poucheret P, Rapior S (2007) Activités biologiques des champignons: utilisations en médecine traditionnelle. Annales de la Société d’Horticulture et d’Histoire Naturelle de l’Hérault 147:77–88
Fukushima M, Nakano M, Morii Y, Ohashi T, Fujiwara Y, Sonoyama K (2000) Hepatic LDL receptor mRNA in rats is increased by dietary mushroom (Agaricus bisporus) fiber and sugar beet fiber. J Nutr 130:2151–2156
Gallagher AM, Flatt PR, Duffy G, Abdel-Wahab YHA (2003) The effects of traditional antidiabetic plants on in vitro glucose diffusion. Nutr Res 23:413–424
Gao Y, Lan J, Dai X, Ye J, Zhou S (2004) A phase I/II study of ling zhi mushroom Ganoderma lucidum (W.Curt.:Fr.) Lloyd (Aphyllophoromycetideae) extract in patients with type II diabetes mellitus. Int J Med Mushr 6:33–39
Ge ZW, Yang ZL, Vellinga EC (2010) The genus Macrolepiota (Agaricaceae, Basidiomycota) in China. Fungal Divers 45:81–98
Geosel A, Sipos L, Stefanovits-Banyai E, Kokai Z, Gyorfi J (2011) Antioxidant, polyphenol, and sensory analysis of Agaricus bisporus and Agaricus subrufescens Cultivars. Acta Alimentaria 40:33–40
Ghaly IS, Ahmed ES, Booles HF, Farag IM, Nada SA (2011) Evaluation of antihyperglycemic action of oyster mushroom (Pleurotus ostreatus) and its effect on DNA damage, chromosome aberrations and sperm abnormalities in streptozotocin-induced diabetic rats. Global Veterinaria 7:532–544
Ghosh S, Ahire M, Patil S, Jabgunde A, Dusane MB, Joshi BN, Pardesi K, Jachak S, Dhavale DD, Chopade BA (2012) Antidiabetic activity of Gnidia glauca and Dioscorea bulbifera: potent amylase and glucosidase inhibitors. Evid Based Complement Alternat Med ID 929051:10 p doi:10.1155/2012/929051
Goldberg RB (2006) Lifestyle interventions to prevent type 2 diabetes. Lancet 368:1634–1636
Goldfine AB, Simonson DC, Folli F, Patti ME, Kahn CR (1995) In vivo and in vitro studies of vanadate in human and rodent diabetes mellitus. Mol Cell Biochem 153:217–231
Gossain VV, Aldasouqi S (2010) The challenge of undiagnosed pre-diabetes, diabetes and associated cardiovascular disease Review article. Int J Diabetes Mellitus 2:43–46
Goyal RK, Mehta AA, Mahajan SG (2008) Classification of herbal antidiabetic based on mechanism of action and chemical constituents. Recent Progress Med Plants 20:65–110
Gray AM, Flatt PR (1998) Insulin-releasing and insulin-like activity of Agaricus campestris (mushroom). J Endocrinol 157:259–266
Greevy RA Jr, Huizinga MM, Roumie CL, Grijalva CG, Murff H, Liu X, Griffin MR (2011) Comparisons of persistence and durability among three oral antidiabetic therapies using electronic prescription-fill data: the impact of adherence requirements and stockpiling. Clin Pharmacol Ther 90:813–819
Grienke U, Mihály-Bison J, Schuster D, Afonyushkin T, Binder M, Guan SH, Cheng CR, Wolber G, Stuppner H, Guo DA, Bochkov VN, Rollinger JM (2011) Pharmacophore-based discovery of FXR-agonists. Part II: identification of bioactive triterpenes from Ganoderma lucidum. Bioorg Med Chem 19:6779–6791
Guillamón E, García-Lafuente A, Lozano M, D’Arrigo M, Rostagno MA, Villares A, Martínez JA (2010) Edible mushrooms: role in the prevention of cardiovascular diseases. Fitoterapia 81:715–723
Guillamón E, Garcia-Lafuente A, Lozano M, Moro C, Palacios I, D’Arrigo M, Martinez JA, Villares A (2011) Mushroom proteins potential therapeutic agents. Agro Food Industry Hi-tech 22:42–44
Gunde-Cimerman N, Plemenitas A, Cimerman A (1993) Pleurotus fungi produce mevinolin, an inhibitor of HMG CoA reductase. FEMS Microbiol Lett 113:333–337
Gunde-Cimerman N, Plemenitas A (2001) Hypocholesterolemic activity of the genus Pleurotus (Jacq.: Fr.) P. Kumm. (Agaricales s. l., Basidiomycetes). Int J Med Mushr 3:395–397
Guo QC, Zhang C (1995) Clinical observations of adjunctive treatment of 20 diabetic patients with JinShuiBao capsule. J Admin Tradit Chin Med 5:22
Guo FC, Savelkoul HFJ, Kwakkel RP, Williams BA, Verstegen MWA (2003) Immunoactive, medicinal properties of mushroom and herb polysaccharides and their potential use in chicken diets. World’s Poultry Sci J 59:427–440
Guo JY, Han CC, Liu YM (2010) A contemporary treatment approach to both diabetes and depression by Cordyceps sinensis, rich in vanadium. Evid Based Complement Alternat Med 7:387–389
Guo J, Li C, Wang J, Liu Y, Zhang J (2011) Vanadium-enriched Cordyceps sinensis, a contemporary treatment approach to both diabetes and depression in rats. Evid Based Complement Alternat Med 450316: 6 p doi:10.1093/ecam/neq058
Gupta V, Vinay DG, Rafiq S, Kranthikumar MV, Janipalli CS, Giambartolomei C, Evans DM, Mani KR, Sandeep MN, Taylor AE, Kinra S, Sullivan RM, Bowen L, Timpson NJ, Smith GD, Dudbridge F, Prabhakaran D, Ben-Shlomo Y, Reddy KS, Ebrahim S, Chandak GR, Indian Migration Study Group (2012) Association analysis of 31 common polymorphisms with type 2 diabetes and its related traits in Indian sib pairs. Diabetologia 55:349–357
Hagopian WA, Erlich H, Lernmark A, Rewers M, Ziegle AG et al (2011) Environmental determinants of diabetes in the young (TEDDY): genetic criteria and international diabetes risk screening of 421 000 infants. Pediatr Diabetes 12:733–743
Halpern GM (2010) Medicinal mushrooms. Prog Nutr 12:29–36
Han C, Liu T (2009) A comparison of hypoglycemic activity of three species of basidiomycetes rich in vanadium. Biol Trace Elem Res 127:177–182
Han SB, Lee CW, Jeon YJ, Hong ND, Yoo ID, Yang KH et al (1999) The inhibitory effect of polysaccharides isolated from Phellinus linteus on tumor growth and metastasis. Immunopharmacol 41:157–164
Han SB, Lee CW, Kang JS, Yoon YD, Lee KH, Lee K, Park SK, Kim HM (2006a) Acidic polysaccharide from Phellinus linteus inhibits melanoma cell metastasis by blocking cell adhesion and invasion. Int Immunopharmacol 6:697–702
Han C, Yuan J, Wang Y, Li L (2006b) Hypoglycemic activity of fermented mushroom of Coprinus comatus rich in vanadium. J Trace Elem Med Biol 20:191–196
Hansen MB, Jensen ML, Carstensen B (2012) Causes of death among diabetic patients in Denmark. Diabetologia 55:294–302
Hao M, Head WS, Gunawardana SC, Hasty AH, Piston DW (2007) Direct effect of cholesterol on insulin secretion; a novel mechanism for pancreatic β-cell dysfunction. Diabetes 56:2328–2338
Hawksworth DL (2001) Mushrooms: the extent of the unexplored potential. Int J Med Mushr 3:333–337
Higaki M, Eguchi F, Zhang J, Kikukawa T, Abe C, Kato K, Hasegawa K, Watanabe Y (2005) Improvement of pancreatic beta-cells by hot water extract from cultured Agaricus blazei (CJ-01) fruiting bodies in GK rats. J Tradit Med 17:205–214
Hobbs C (1995) Medicinal mushrooms: an exploration of tradition, healing, and culture. Botanica Press, Santa Cruz, USA, 251p
Hobbs C (2000) Medicinal value of Lentinus edodes (Berk.) Sing. (Agaricomycetideae). A literature review. Int J Med Mushr 2:287–302
Hobbs CR (2004) Medicinal value of Turkey Tail fungus Trametes versicolor (L.:Fr.) Pilát (Aphyllophoromycetideae). Int J Med Mushr 6:195–218
Hobbs CR (2005) The chemistry, nutritional value, immunopharmacology, and safety of the traditional food of medicinal split-gill fungus Schizophyllum commune Fr.:Fr. (Aphyllophoromycetideae). A literature review. Int J Med Mushr 7:127–140
Holliday J, Cleaver M, Wasser SP (2005) Cordyceps. Encyclopedia of dietary supplements: Dekker Encyclopedias, Taylor and Francis Publishing 1–13
Hong L, Xun M, Wutong W (2007) Anti-diabetic effect of an alpha-glucan from fruit body of maitake (Grifola frondosa) on KK-Ay mice. J Pharm Pharmacol 59:575–582
Horio H, Ohtsuru M (2001) Maitake (Grifola frondosa) improve glucose tolerance of experimental diabetic rats. J Nutr Sci Vitaminol 47:57–63
Horton ES (1995) NIDDM - The devastating disease. Diabetes Res Clin Pr 28:S3–S11
Hossain S, Hashimoto M, Choudhury EK, Alam N, Hussain S, Hasan M, Choudhury SK, Mahmud I (2003) Dietary mushroom (Pleurotus ostreatus) ameliorates atherogenic lipid in hypercholesterolaemic rats. Clin Exp Pharmacol Physiol 30:470–475
Howlett HC, Bailey CJ (1999) A risk-benefit assessment of metformin in type 2 diabetes mellitus. Drug Saf 20:489–503
Hsu CH, Liao YL, Lin SC, Hwang KC, Chou P (2007) The mushroom Agaricus blazei murill in combination with metformin and gliclazide improves insulin resistance in type 2 diabetes: a randomized, double-blinded, and placebo-controlled clinical trial. J Altern Complement Med 13:97–102
Hu FB, Manson JE, Stampfer MJ, Colditz G, Liu S, Solomon CG, Willett WC (2001) Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med 345:790–797
Hu SH, Wang JC, Lien JL, Liaw ET, Lee MY (2006a) Antihyperglycemic effect of polysaccharide from fermented broth of Pleurotus citrinopileatus. Appl Microbiol Biotechnol 70:107–113
Hu SH, Liang ZC, Chia YC, Lien JL, Chen KS, Lee MY, Wang JC (2006b) Antihyperlipidemic and antioxidant effects of extracts from Pleurotus citrinopileatus. J Agric Food Chem 54:2103–2110
Hu T, Liu P, Ni Y, Lu C (2012) Isolation, purification and effects of hypoglycemic functional polysaccharides from Inonotus obliquus. African J Biotechnol 11:7738–7743
Huang GJ, Hsieh WT, Chang HY, Huang SS, Lin YC, Kuo YH (2011) α-Glucosidase and aldose reductase inhibitory activities from the fruiting body of Phellinus merrillii. J Agric Food Chem 59:5702–5706
Hung WT, Wang SH, Chen CH, Yang WB (2008) Structure determination of β-glucans from Ganoderma lucidum with matrix assisted laser desorption/ionization (MALDI) Mass Spectrometry. Molecules 13:1538–1550
Huseini HF, Kianbakht S, Hajiaghaee R, Dabaghian FH (2012) Anti-hyperglycemic and anti-hypercholesterolemic effects of Aloe vera leaf gel in hyperlipidemic type 2 diabetic patients: a randomized double-blind placebo-controlled clinical trial. Planta Med 78:311–316
Hwang HS, Yun JW (2010) Hypoglycemic effect of polysaccharides produced by submerged mycelial culture of Laetiporus sulphureus on streptozotocin-induced diabetic rats. Biotechnol Bioprocess Eng 15:173–181
Hwang HJ, Kim SW, Lim JM, Joo JH, Kim HO, Kim HM, Yun JW (2005) Hypoglycemic effect of crude exopolysaccharides produced by a medicinal mushroom Phellinus baumii in streptozotocin-induced diabetic rats. Life Sci 76:3069–3080
Hyde KD (2001) Where are the missing fungi; does Hong Kong have any answers. Mycol Res 105:1514–1518
Hyde KD, Bahkali AH, Moslem MA (2010) Fungi - an unusual source for cosmetics. Fungal Divers 43:1–9
Ianculov I, Botau D, Bordean DM, Cucu M, Bolda V, Pruna P (2010) Determination of total proteins in gemotherapeutic preparations with the Folin-Ciocalteu reagent. Romanian Biotechnol Lett 15:5410–5416
Ichimura T, Otake T, Mori H, Maruyama S (1999) HIV-1 protease inhibition and anti-HIV effect of natural and synthetic water-soluble lignin-like substance. Biosci Biotech and Bioch 63:2202–2204
Igel LI, Powell AG, Apovian CM, Aronne LJ (2012) Advances in medical therapy for weight loss and the weight-centric management of type 2 diabetes mellitus. Curr Atheroscler Rep 14:60–69
Ishii PL, Prado CK, Mauro MO, Carreira CM, Mantovani MS, Ribeiro LR, Dichi JB, Oliveira RJ (2011) Evaluation of Agaricus blazei in vivo for antigenotoxic, anticarcinogenic, phagocytic and immunomodulatory activities. Regul Toxicol Pharmacol 59:412–422
Jakopovich I (2011) New dietary supplements from medicinal mushrooms: Dr Myko San—a registration report. Int J Med Mushr 13:307–313
Jang JS, Lee JS, Lee JH, Kwon DS, Lee KE, Lee SY, Hong EK (2010) Hispidin produced from Phellinus linteus protects pancreatic β-cells from damage by hydrogen peroxide. Arch Pharm Res 33:853–861
Jayakumar T, Ramesh E, Geraldine P (2006) Antioxidant activity of the oyster mushroom, Pleurotus ostreatus, on CCl4-induced liver injury in rats. Food Chem Toxicol 44:1989–1996
Jenkins NT, Hagberg JM (2011) Aerobic training effects on glucose tolerance in prediabetic and normoglycemic humans. Med Sci Sports Exerc 43:2231–2240
Jeong SC, Jeong YT, Yang BK, Islam R, Koyyalamudi SR, Pang G, Cho KY, Song CH (2010) White button mushroom (Agaricus bisporus) lowers blood glucose and cholesterol levels in diabetic and hypercholesterolemic rats. Nutr Res 30:49–56
Jia W, Gaoz W, Tang L (2003) Antidiabetic herbal drugs officially approved in China. Phytother Res 17:1127–1134
Jia J, Zhang X, Hu YS, Wu Y, Wang QZ, Li NN, Guo QC, Dong XC (2009) Evaluation of in vivo antioxidant activities of Ganoderma lucidum polysaccharides in STZ-diabetic rats. Food Chem 115:32–36
Jiangwei M, Zengyong Q, Xia X (2011) Optimisation of extraction procedure for black fungus polysaccharides and effect of the polysaccharides on blood lipid and myocardium antioxidant enzymes activities. Carbohyd Polym 84:1061–1068
Johnston N (2005) Medicinal mushroom cuts off prostate cancer cells’ blood supply. Drug Discov Today 10:1584
Joo JI, Kim DH, Yun JW (2010) Extract of Chaga mushroom (Inonotus obliquus) stimulates 3T3-L1 adipocyte differentiation. Phytother Res 24:1592–1599
Kahlos K (1994) Antifungal activity of cysteine, its effect on C-21 oxygenated lanosterol derivatives and other lipid in Inonotus obliquus, in vitro. Appl Microbiol Biot 3:339–385
Kakkar R, Mantha SV, Radhi J, Prasad K, Kalra J (1998) Increased oxidative stress in rat liver and pancreas during progression of streptozotocin-induced diabetes. Clin Sci (Lond) 94:623–632
Kan WC, Wang HY, Chien CC, Li SL, Chen YC, Chang LH, Cheng CH, Tsai WC, Hwang JC et al (2012) Effects of extract from solid-state fermented Cordyceps sinensis on type 2 diabetes mellitus. Evid Based Complement Alternat Med 743107:10 p. doi:10.1155/2012/743107
Kanazawa K (2011) Bioavailability of non-nutrients for preventing lifestyle related diseases. Trends Food Sci Tech 22:655–659
Kaparianos A, Argyropoulou E, Sampsonas F, Karkoulias K, Tsiamita M, Spiropoulos K (2008) Pulmonary complications in diabetes mellitus. Chronic Respiratory Disease 5:101–108
Karou DS, Tchacondo T, Djikpo Tchibozo MA, Abdoul-Rahaman S, Anani K, Koudouvo K, Batawila K, Agbonon A, Simpore J, de Souza C (2011) Ethnobotanical study of medicinal plants used in the management of diabetes mellitus and hypertension in the Central Region of Togo. Pharm Biol 49:1286–1297
Kaur J, Singh P, Sowers JR (2002) Diabetes and cardiovascular diseases. Am J Ther 9:510–515
Kawagishi H, Shimada A, Hosokawa S, Mori H, Sakamoto H, Ishiguro Y et al (1996) Erinacines E, F, and G, stimulators of nerve growth factor (NGF)-synthesis, from the mycelia of Hericium erinaceum. Tetrahedron Lett 37:7399–7402
Kawasaki E, Abiru N, Eguchi K (2004) Prevention of type 1 diabetes: from the view point of β-cell damage. Diabetes Res Clin Pract 66:S27–S32
Kerr D, Partridge H, Knott J, Thomas PW (2011) HbA1c 3 months after diagnosis predicts premature mortality in patients with new onset type 2 diabetes. Diabet Med 28:1520–1524
Kerrigan RW (2005) Agaricus subrufescens, a cultivated edible and medicinal mushroom, and its synonyms. Mycologia 97:12–24
Khan MA, TaniaM ZDZ, Chen HC (2010) Cordyceps Mushroom: a potent anticancer nutraceutical. Open Nutraceuticals J 3:179–183
Kidd PM (2000) The use of mushroom Glucans and proteoglycans in cancer treatment. Altern Med Rev 5:4–27
Kiho T, Tsujimura Y, Sakushima M, Usui S, Ukai S (1994) Polysaccharides in fungi. XXXIII. Hypoglycemic activity of an acidic polysaccharide (AC) from Tremella fuciformis. Yakugaku zasshi 114:308–315
Kiho T, Yamane A, Hui J, Usui S, Ukai S (1996) Polysaccharide in fungi. XXXVI. Hypoglycemic activity of a polysaccharide (CS-F30) from the cultural mycelium of Cordyceps sinensis and its effects on glucose metabolism in mouse liver. Biol Pharm Bull 19:294–296
Kiho T, Ookubo K, Usui S, Ukai S, Hirano K (1999) Structural features and hypoglycemic activity of a polysaccharide (CS-F10) from the cultured mycelium of Cordyceps sinensis. Biol Pharm Bull 22:966–970
Kiho T, Kochi M, Usui S, Hirano K, Aizawa K, Inakuma T (2001) Antidiabetic effect of an acidic polysaccharide (TAP) from Tremella aurantia and its degradation product (TAP-H). Biol Pharm Bull 24:1400–1403
Kim OH, Yang BK, Hur NI, Das S, Yun JW, Choi YS, Song CH (2001a) Hypoglycemic effects of mycelia produced from submerged culture of Phellinus linteus (Berk. et Curt.) Teng (Aphyllophoromycetideae) in streptozotocin-induced diabetic rats. Int J Med Mushr 3:21–26
Kim DH, Yang BK, Jeong SC, Park JB, Cho SP, Das S, Yun JW, Song CH (2001b) Production of a hypoglycemic, extracellular polysaccharide from the submerged culture of the mushroom, Phellinus linteus. Biotechnol Lett 23:513–517
Kim DH, Yang BK, Jeong SC, Hur NJ, Das S, Yun JW, Choi JW, Lee YS, Song CH (2001c) A preliminary study on the hypoglycemic effect of the exo-polymers produced by five different medicinal mushrooms. J Microbiol Biotechnol 11:167–171
Kim YW, Kim KH, Choi HJ, Lee DS (2005) Anti-diabetic activity of beta-glucans and their enzymatically hydrolyzed oligosaccharides from Agaricus blazei. Biotechnol Lett 27:483–487
Kim YO, Park HW, Kim JH, Lee JY, Moon SH, Shin CS (2006) Anticancer effect and structural characterization of endo-polysaccharide from cultivated mycelia of Inonotus obliquus. Life Sci 79:72–80
Kim SK, Hong UP, Kim JS, Kim CH, Lee KW, Choi SE, Park KH, Lee MW (2007) Antidiabetic effect of Auricularia auricula mycelia in streptozotocin-induced diabetic rats. Natural Product Sci 13:390–393
Kim JI, Kang MJ, Im J, Seo YJ, Lee YM, Song JH, Lee JH, Kim ME (2010a) Effect of King Oyster Mushroom (Pleurotus eryngii) on Insulin Resistance and Dyslipidemia in db/db Mice. Food Sci biotechnol 19:239–242
Kim HM, Kang JS, Kim JY, Park SK, Kim HS, Lee YJ, Yun J, Hong JT, Kim Y, Han SB (2010b) Evaluation of antidiabetic activity of polysaccharide isolated from Phellinus linteus in non-obese diabetic mouse. Int Immunopharmacol 10:72–78
Kim SP, Kang MY, Kim JH, Nam SH, Friedman M (2011) Composition and mechanism of antitumor effects of Hericium erinaceus mushroom extracts in tumor-bearing mice. J Agric Food Chem 59:9861–9869
King H (1998) Epidemiology of glucose intolerance and gestational diabetes in women of childbearing age. Diabetes Care 21:B9–B13
Kirkham S, Akilen R, Sharma S, Tsiami A (2009) The potential of cinnamon to reduce blood glucose levels in patients with type 2 diabetes and insulin resistance. Diabetes Obes Metab 11:1100–1113
Kitagawa T, Owada M, Urakami T, Tajima N (1994) Epidemiology of type 1 (insulin-dependent) and type 2 (non insulin-dependent) diabetes mellitus in Japanese children. Diabetes Res Clin Pract 24:S7–S13
Kobayashi T (1994) Subtype of insulin-dependent diabetes mellitus (IDDM) in Japan: Slowly progressive IDDM—the clinical characteristics and pathogenesis of the syndrome. Diabetes Res Clin Pract 24:S95–S99
Komura DL, Ruthes AC, Carbonero ER, Alquini G, Rosa MCC, Sassaki GL, Iacomini M (2010) The origin of mannans found in submerged culture of basidiomycetes. Carbohyd Polym 79:1052–1056
Konno S (2001) Maitake D-fraction: apoptosis inducer and immune enhancer. Altern Complementary Ther 17:102–107
Koyyalamudi SR, Jeong SC, Cho KY, Pang G (2009a) Vitamin B12 is the active corrinoid produced in cultivated white button mushrooms (Agaricus bisporus). J Agric Food Chem 57:6327–6333
Koyyalamudi SR, Jeong SC, Song CH, Cho KY, Pang G (2009b) Vitamin D2 formation and bioavailability from Agaricus bisporus button mushrooms treated with ultraviolet irradiation. J Agric Food Chem 57:3351–3355
Krentz AJ, Bailey CJ (2005) Oral antidiabetic agents: current role in type 2 diabetes mellitus. Drugs 65:385–411
Kuller LH (2006) Nutrition, lipids and cardiovascular disease. Nutr Rev 64:S15–S26
Kuzuya T, Nakagawa S, Satoh J, Kanazawa Y, Iwamoto Y, Kobayashi M et al (2002) Report of the Committee on the classification and diagnostic criteria of diabetes mellitus. Diabetes Res Clin Pract 55:65–85
Kwon AH, Qiu Z, Hashimoto M, Yamamoto K, Kimura T (2008) Effects of medicinal mushroom (Sparassis crispa) on wound healing in streptozotocin-induced diabetic rats. Am J Surg 197(4):503–509
Kwon JS, Lee JS, Shin WC, Lee KE, Hong EK (2009) Optimization of culture conditions and medium components for the production of mycelial biomass and exo-polysaccharides with Cordyceps militaris in liquid culture. Biotechnol Bioprocess Eng 14:756–762
Laaksonen DE, Niskanen L, Lakka HM, Lakka TA, Uusitupa M (2004) Epidemiology and treatment of the metabolic syndrome. Ann Med 36:332–346
Lange LJ, Piette JD (2005) Perceived health status and perceived diabetes control: psychological indicators and accuracy. J Psychosom Res 58(2):129–137
Lee JS, Hong EK (2011) Immunostimulating activity of the polysaccharides isolated from Cordyceps militaris. Int Immunopharmacol 11:1226–1233
Lee IK, Yun BS (2011) Styrylpyrone-class compounds from medicinal fungi Phellinus and Inonotus spp., and their medicinal importance. J Antibiot 64:349–359
Lee BH, Kim HJ, Chang JS (1999) Inhibitory effect of Coprinus comatus ethanol extract on the liver damage in benzopyrene-treated mice. J Korean Society Food Sci Nutr 28:1364–1368
Lee BC, Bae JT, Pyo HB, Choe TB, Kim SW, Hwang HJ, Yun JW (2004) Submerged culture conditions for the production of mycelial biomass and exopolysaccharides by the edible Basidiomycete Grifola frondosa. Enzyme Microb Technol 35:369–376
Lee YS, Kang YH, Jung JY, Lee S, Ohuchi K, Shin KH, Kang IJ, Park JH, Shin HK, Lim SS (2008a) Protein glycation inhibitors from the fruiting body of Phellinus linteus. Biol Pharm Bull 31:1968–1972
Lee IK, Lee JH, Yun BS (2008b) Polychlorinated compounds with PPAR-gamma agonistic effect from the medicinal fungus Phellinus ribis. Bioorg Med Chem Lett 18(16):4566–4568
Lee YS, Kang IJ, Won MH, Lee JY, Kim JK, Lim SS (2010) Inhibition of protein tyrosine phosphatase 1beta by hispidin derivatives isolated from the fruiting body of Phellinus linteus. Nat Prod Commun 5(12):1927–1930
Lee KH, Morris-Natschke SL, Yang X, Huang R, Zhou T, Wu SF, Shi Q, Itokawa H (2012) Recent progress of research on medicinal mushrooms, foods, and other herbal products used in traditional Chinese medicine. J Traditional Complement Med 2(2):84–95
Leung PH, Zhao S, Ho KP, Wu JY (2009) Chemical properties and antioxidant activity of exopolysaccharides from mycelial culture of Cordyceps sinensis fungus Cs-HK1. Food Chem 114:1251–1256
Li DH (2012) Diabetes and pancreatic cancer. Mol Carcinog 51(1):64–74
Li SP, Zhao KJ, Ji ZN, Song ZH, Dong TT, Lo CK, Cheung JK, Zhu SQ, Tsim KW (2003) A polysaccharide isolated from Cordyceps sinensis, a traditional Chinese medicine, protects PC12 cells against hydrogen peroxide-induced injury. Life Sci 73(19):2503–2513
Li WL, Zheng HC, Bukuru J, Kimpe N (2004) Natural medicines used in the traditional Chinese medical system for therapy of diabetes mellitus. J Ethnopharmacol 92:1–21
Li SP, Zhang GH, Zeng Q, Huang ZG, Wang YT, Dong TT, Tsim KW (2006) Hypoglycemic activity of polysaccharide, with antioxidation, isolated from cultured Cordyceps mycelia. Phytomedicine 13(6):428–433
Li B, Lu F, Suo XM (2010) Glucose lowering activity of Coprinus comatus. Agro Food Industry Hi-Tech 21:15–17
Li TH, Hou CC, Chang CLT, Yang WC (2011a) Anti-hyperglycemic properties of crude extract and triterpenes from Poria cocos. Evid Based Complement Alternat Med 128402:8p doi:10.1155/2011/128402
Li N, Li L, Fang JC, Wong JH, Ng TB, Jiang Y, Wang CR, Zhang NY, Wen TY, Qu LY, Lv PY, Zhao R, Shi B, Wang YP, Wang XY, Liu F (2011b) Isolation and identification of a novel polysaccharide-peptide complex with antioxidant, antiproliferative and hypoglycaemic activities from the abalone mushroom. Biosci Rep 32(3):221–228
Li N, Li L, Fang JC, Wong JH, Ng TB, Jiang Y, Wang CR, Zhang NY, Wen TY, Qu Li Y et al (2012) Isolation and identification of a novel polysaccharide-peptide complex with antioxidant, anti-proliferative and hypoglycaemic activities from the abalone mushroom. Biosci Rep 32(3):221–228
Liday C (2011) Overview of the guidelines and evidence for the pharmacologic management of type 2 diabetes mellitus. Pharmacotherapy 31(12):37S–43S
Lima CU, Cordova CO, Nóbrega Ode T, Funghetto SS, Karnikowski MG (2011) Does the Agaricus blazei Murill mushroom have properties that affect the immune system? An integrative review. J Med Food 14(1–2):2–8
Lin JT, Liu WH (2006) ο-Orsellinaldehyde from the submerged culture of the edible mushroom Grifola frondosa exhibits selective cytotoxic effect against Hep 3B cells through apoptosis. J Agric Food Chem 54:7564–7569
Lindequist U, Niedermeyer THJ, Jülich WD (2005) The pharmacological potential of mushrooms. Evid Based Complement Alternat Med 2:285–299
Liu S, Choi HK, Ford E, Song Y, Klevak A, Buring JE, Manson JE (2006) A prospective study of dairy intake and the risk of type 2 diabetes in women. Diabetes Care 29:1579–1584
Liu YW, Gao JL, Guan J, Qian ZM, Feng K, Li SP (2009) Evaluation of antiproliferative activities and action mechanisms of extracts from two species of Ganoderma on tumor cell lines. J Agric Food Chem 57:3087–3093
Liu YT, Sun J, Luo ZY, Rao SQ, Su YJ, Xu RR, Yang YJ (2012) Chemical composition of five wild edible mushrooms collected from Southwest China and their antihyperglycemic and antioxidant activity. Food ChemToxicol 50(5):1238–1244
Lo HC, Wasser SP (2011) Medicinal mushrooms for glycemic control in diabetes mellitus: history, current status, future perspectives, and unsolved problems (review). Int J Med Mushr 13:401–426
Lo HC, Tu ST, Lin KC, Lin SC (2004) The anti-hyperglycemic activity of the fruiting body of Cordyceps in diabetic rats induced by nicotinamide and streptozotocin. Life Sci 74(23):2897–2908
Lo HC, Tsai FA, Wasser SP, Yang JG, Huang BM (2006a) Effects of ingested fruiting bodies, submerged culture biomass, and acidic polysaccharide glucuronoxylomannan of Tremella mesenterica Retz.:Fr. on glycemic responses in normal and diabetic rats. Life Sci 78(17):1957–1966
Lo HC, Hsu TH, Tu ST, Lin KC (2006b) Anti-hyperglycemic activity of natural and fermented Cordyceps sinensis in rats with diabetes induced by nicotinamide and streptozotocin. Am J Chin Med 34(5):819–832
Lo HC, Hsu TH, Chen CY (2008) Submerged culture mycelium and broth of Grifola frondosa improve glycemic responses in diabetic rats. Am J Chin Med 36(2):265–285
Lu XM, Chen HX, Dong P, Fu LL, Zhang X (2010) Phytochemical characteristics and hypoglycaemic activity of fraction from mushroom Inonotus obliquus. J Sci Food Agr 90(2):276–280
Luo X, Xu X, Yu M, Yang Z, Zheng L (2008) Characterisation and immunostimulatory activity of an α-(1→6)-D-glucan from the cultured Armillaria tabescens mycelia. Food Chem 111:357–363
Lustman PJ, Amado H, Wetzel RD (1983) Depression in diabetics: a critical appraisal. Comp Psychiatry 24:65–74
Lv Y, Han L, Yuan C, Guo J (2009) Comparison of hypoglycemic activity of trace elements absorbed in fermented mushroom of Coprinus comatus. Biol Trace Elem Res 131(2):177–185
Ma ZJ, Fu Q (2009) Comparison of hypoglycemic activity and toxicity of vanadium (iv) and vanadium (v) absorbed in fermented mushroom of Coprinus comatus. Biol Trace Element Res 132(1–3):278–284
Majithia AR, Jablonski KA, McAteer JB, Mather KJ, Goldberg RB, Kahn SE, Florez JC, DPP Research Group (2011) Association of the SLC30A8 missense polymorphism R325W with proinsulin levels at baseline and after lifestyle, metformin or troglitazone intervention in the Diabetes Prevention Program. Diabetologia 54(10):2570–2574
Manohar V, Talpur NA, Echard BW, Lieberman S, Preuss HG (2002) Effects of a water-soluble extract of maitake mushroom on circulating glucose/insulin concentrations in KK mice. Diabetes Obes Metab 4:43–48
Martin KR (2010) The bioactive agent ergothioneine, a key component of dietary mushrooms, inhibits monocyte binding to endothelial cells characteristic of early cardiovascular disease. J Med Food 13(6):1340–1346
Mathé D (1995) Dyslipidemia and diabetes: animal models. Diabete Metab 21:106–111
Matsuur H, Asakawa C, Kurimoto M, Mizutani J (2002) Alpha-glucosidase inhibitor from the seeds of balsam pear (Momordica charantia) and the fruit bodies of Grifola frondosa. Biosci Biotechnol Biochem 66:1576–1578
Mattila P, Könkö K, Eurola M, Pihlava JM, Astola J, Vahteristo L, Hietaniemi V, Kumpulainen J, Valtonen M, Piironen V (2001) Contents of vitamins, mineral elements, and some phenolic compounds in cultivated mushrooms. J Agric Food Chem 49:2343–2348
Mattila P, Salo-Väänänen P, Könkö K, Aro H, Jalava T (2002) Basic composition and amino acid contents of mushrooms cultivated in Finland. J Agric Food Chem 50:6419–6422
Meng G, Zhu H, Yang S, Wu F, Zheng H, Chen E, Xu J (2011) Attenuating effects of Ganoderma lucidum polysaccharides on myocardial collagen cross-linking relates to advanced glycation end product and antioxidant enzymes in high-fat-diet and streptozotocin-induced diabetic rats. Carbohyd Polym 84:180–185
Milner JA (2000) Functional foods: the US perspective. Am J Clin Nutr 71:1654S–1659S
Mirmiran P, Noori N, Zavareh MB, Azizi F (2009) Fruit and vegetable consumption and risk factors for cardiovascular disease. Metabolism 58:460–468
Misra A, Lalan MS, Singh VK, Govil JN (2009) Role of natural polysaccharides in treatment and control of diabetes. Chemistry and medicinal value book series. Recent Progr Med Plants 25:347–373
Mizuno T (1999a) Medicinal effects and utilization of Cordyceps (Fr.) Link (Ascomycetes) and Isaria Fr. (Mitosporic fungi) Chinese caterpillar fungi, “Tochukaso”. Int J Med Mushr 1:251–262
Mizuno T (1999b) The extraction and development of antitumor-active polysaccharides from medicinal mushrooms in Japan. Int J Med Mushr 1:9–29
Mizuno T, Zhuang C, Abe K, Okamoto H, Kiho T, Ukai S, Leclerc S, Meijer L (1999) Antitumor and hypoglycemic activities of polysaccharides from the sclerotia and mycelia of Inonotus obliquus (Pers.:Fr.) Pil. (Aphyllophoromycetideae). Int J Med Mushr 1:301–316
Monnier L, Grimaldi A, Charbonnel B, Iannascoli F, Lery T, Garofano A, Childs M (2004) Management of French patients with type 2 diabetes mellitus in medical general practice: report of the Mediab observatory. Diabetes Metab 30(1):35–42
Moradali MF, Mostafavi H, Ghods S, Hedjaroude GA (2007) Immunomodulating and anticancer agents in the realm of macromycetes fungi (macrofungi). Int Immunopharmacol 7:701–724
Mori K, Kobayashi C, Tomita T, Inatomi S, Ikeda M (2008) Antiatherosclerotic effect of the edible mushrooms Pleurotus eryngii (Eringi), Grifola frondosa (Maitake), and Hypsizygus marmoreus (Bunashimeji) in apolipoprotein E-deficient mice. Nutr Res 28(5):335–342
Mori K, Inatomi S, Ouchi K, Azumi Y, Tuchida T (2009) Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment: a double-blind placebo-controlled clinical trial. Phytother Res 23(3):367–372
Morrato EH, Hill JO, Wyatt HR, Ghushchyan V, Sullivan PW (2007) Physical activity in U.S. adults with diabetes and at risk for developing diabetes, 2003. Diabetes Care 30(2):203–209
Moutzouri E, Tsimihodimos V, Rizos E, Elisaf M (2011) Prediabetes: To treat or not to treat? Eur J Pharmacol 672:9–19
Mujić I, Zeković Z, Vidović S, Radojković M, Zivković J, Gođevac D (2011) Fatty acid profiles of four wild mushrooms and their potential benefits for hypertension treatment. J Med Food 14(11):1330–1337
Musselman DL, Betan E, Larsen H, Phillips LS (2003) Relationship of depression to diabetes types 1 and 2: epidemiology, biology, and treatment. Biol Psychiatry 54(3):317–329
Muszyńska B, Sułkowska-Ziaja K, Wołkowska M, Ekiert H (2011) Review Chemical, pharmacological, and biological characterization of the culinary-medicinal honey mushroom, Armillaria mellea (Vahl) P. Kumm. (Agaricomycetideae): a review. Int J Med Mushr 13:167–175
Narayan KM, Williamson DF (2010) Prevention of type 2 diabetes: risk status, clinic, and community. J Gen Intern Med 25(2):154–157
Nichols GA, Hillier TA, Brown JB (2007) Progression from newly acquired impaired fasting glucose to type 2 Diabetes. Diabetes Care 30(2):228–233
Nishizawa K, Torii K, Kawasaki A, Katada M, Ito M, Terashita K (2007) Antidepressant-like effect of Cordyceps sinensis in the mouse tail suspension test boil. Biol Pharm Bull 30:1758–1762
Niwa A, Tajiri T, Higashino H (2011) Ipomoea batatas and Agarics blazei ameliorate diabetic disorders with therapeutic antioxidant potential in streptozotocin-induced diabetic rats. J Clin Biochem Nutr 48(3):194–202
Norris SL, Lau J, Smith SJ, Schmid CH, Engelgau MM (2002) Self-management education for adults with type 2 diabetes: a meta-analysis of the effect on glycemic control. Diabetes Care 25(7):1159–1171
O’Hanlon R, Harrington TJ (2011) Diversity and distribution of mushroom forming fungi (Agaricomycetes) in Ireland. Biol Environ 111B:117–133
O’Hanlon R, Harrington TJ (2012) Macrofungal diversity and ecology in four Irish forest types. Fungal Ecology. doi;10.1016/j.funeco.2011.12.008
Oh TW, Kim YA, Jang WJ, Byeon JI, Ryu CH, Kim JO, Ha YL (2010) Semipurified fractions from the submerged-culture broth of Agaricus blazei Murill reduce blood glucose levels in streptozotocin-induced diabetic rats. J Agric Food Chem 58(7):4113–4119
Orsine JVC, Novaes MRCG, Asquieri ER (2012) Nutritional value of Agaricus sylvaticus; mushroom grown in Brazil. Nutr Hosp 27(2):449–455
Osanai T, Tanaka M, Magota K, Tomita H, Okumura K (2012) Coupling factor 6-induced activation of ecto-F1Fo complex induces insulin resistance, mild glucose intolerance and elevated blood pressure in mice. Diabetologia 55:520–529
Otton R, Soriano FG, Verlengia R, Curi R (2004) Diabetes induces apoptosis in lymphocytes. J Endocrinol 182(1):145–156
Papas AM (1996) Determinants of antioxidant status in humans. Lipids 31:77–82
Park YK, Kim JS, Jeon EJ, Kang MH (2009) The improvement of Chaga mushroom (Inonotus obliquus) extract supplementation on the blood glucose and cellular DNA damage in streptozotocin-induced diabetic rats. Korean J Nutr 42(1):5–13
Pastors JC (2003) Medications or lifestyle change with medical nutrition therapy. Curr Diabetes Rep 3(5):386–391
Pastors JG, Warshaw H, Daly A, Franz M, Kulkarni K (2002) The evidence for the effectiveness of medical nutrition therapy in diabetes management. Diabetes Care 25(3):608–613
Paterson RRM (2006) Ganoderma - a therapeutic fungal biofactory (Review). Phytochemistry 67:1985–2001
Percario S, Odorizzi VF, Souza DR, Pinhel MA, Gennari JL, Gennari MS, Godoy MF (2008) Edible mushroom Agaricus sylvaticus can prevent the onset of atheroma plaques in hypercholesterolemic rabbits. Cell Mol Biol (Noisy-le-grand) 54(Suppl OL):1055–1061
Pereira E, Barros L, Martins A, Ferreira ICFR (2012) Towards chemical and nutritional inventory of Portuguese wild edible mushrooms in different habitats. Food Chem 130:394–403
Perera PK, Li Y (2011) Mushrooms as a functional food mediator in preventing and ameliorating diabetes. Funct Foods Health Dis 4:161–171
Petersen RK, Christensen KB, Assimopoulou AN, Fretté X, Papageorgiou VP, Kristiansen K, Kouskoumvekaki I (2011) Pharmacophore-driven identification of PPARγ agonists from natural sources. J Comput Aided Mol Des 25(2):107–116
Petrova RD, Wasser SP, Mahajna J, Denchev CM, Nevo E (2005) Potential role of medicinal mushrooms in breast cancer treatment: current knowledge and future perspectives. Int J Med Mushr 7:141–155
Phillips KM, Ruggio DM, Horst RL, Minor B, Simon RR et al (2011a) Vitamin D and sterol composition of 10 types of mushrooms from retail suppliers in the United States. J Agric Food Chem 59(14):7841–7853
Phillips KM, Ruggio DM, Haytowitz DB (2011b) Folate composition of 10 types of mushrooms determined by liquid chromatography–mass spectrometry. Food Chem 129:630–636
Pickup JC, Mattock MB, Chusney GD, Burt D (1997) NIDDM as a disease of the innate immune system: association of acute phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia 40:1286–1292
Popov D (2011) Novel protein tyrosine phosphatase 1B inhibitors: interaction requirements for improved intracellular efficacy in type 2 diabetes mellitus and obesity control. Biochem Biophys Res Commun 410:377–381
Popović M, Vukmirović S, Stilinović N, Čapo I, Jakovljević V (2010) Anti-oxidative activity of an aqueous suspension of commercial preparation of the mushroom Coprinus comatus. Molecules 15:4564–4571
Poraj-Kobielska M, Kinne M, Ullrich R, Scheibner K, Kayser G, Hammel KE, Hofrichter M (2011) Preparation of human drug metabolites using fungal peroxygenases. Biochem Pharmacol 82:789–796
Porta M, Allione A (2004) Current approaches and perspectives in the medical treatment of diabetic retinopathy. Pharmacol Therapeut 103:167–177
Potenza MV, Mechanick JI (2009) The metabolic syndrome: definition, global impact, and pathophysiology. Nutr Clin Pract 24:560–577
Poucheret P, Verma S, Grynpas MD, McNeill JH (1998) Vanadium and diabetes. Mol Cell Biochem 188(1–2):73–80
Poucheret P, Fons F, Rapior S (2006) Biological and pharmacological activity of higher fungi: 20-year retrospective analysis. Cryptogam Mycol 27:311–333
Pozzilli P, Buzzetti R (2007) A new expression of diabetes: double diabetes. Trends Endocrinol Metab 18:52–57
Pozzilli P, Guglielmi C (2009) Double diabetes: a mixture of type 1 and type 2 diabetes in youth. Endocr Dev 14:151–166
Pozzilli P, Chiara G, Caprio S, Buzzetti R (2011) Obesity, autoimmunity, and double diabetes in youth. Diabetes Care 34:S166–S170
Prasad K (2000) Antioxidant activity of secoisolariciresinol diglucoside-derived metabolites, secoisolariciresinol, enterodiol, and enterolactone. Int J Angiol 9:220–225
Preuss HG, Echard B, Bagchi D, Perricone NV, Zhuang C (2007) Enhanced insulin-hypoglycemic activity in rats consuming a specific glycoprotein extracted from maitake mushroom. Mol Cell Biochem 306:105–113
Prokopenko I, McCarthy MI, Lindgren CM (2008) Type 2 diabetes: new genes, new understanding. Trends Genet 24:613–621
Purnell J (2008) Beyond the diabetes control and complications trial -addressing weight gain in type 1 diabetes. US Endocrinology 4:62–64
Qi L, Parast L, Cai T, Powers C, Gervino EV, Hauser TH, Hu FB, Doria A (2011) Genetic susceptibility to coronary heart disease in type 2 diabetes: 3 independent studies. J Am Coll Cardiol 58(25):2675–2682
Qiang X, YongLie C, QianBing W (2009) Health benefit application of functional oligosaccharides. Carbohyd Polym 77:435–441
Raji KP, Nataraian P, Kurup GM (2009) Anti-hyperglycemic activity of mushroom on serum glucose levels in alloxan induced diabetic rats. Bioscan 4:231–235
Ranjbar SH, Larijani B, Abdollahi M (2011) Recent update on animal and human evidences of promising anti-diabetic medicinal plants: a mini-review of targeting new drugs. Asian J Animal Veterinary Advan 6:1271–1275
Rapior S, Courtecuisse R, Francia C, Siroux Y (2000) Activités biologiques des champignons: recherches actuelles sur les facteurs de risque des maladies cardio-vasculaires. Annales de la Société d’Horticulture et d’Histoire Naturelle de l’Hérault 140:26–31
Rathee S, Rathee D, Rathee D, Kumar V, Rathee P (2012) Mushrooms as therapeutic agents. Revista Brasileira de Farmacognosia 22(2):459–474
Reimann M, Bonifacio E, Solimena M, Schwarz PEH, Ludwig B, Hanefeld M, Bornstein SR (2009) An update on preventive and regenerative therapies in diabetes mellitus. Pharmacol Therapeut 121:317–331
Reis FS, Pereira E, Barros L, João Sousa M, Martins A, Ferreira ICFR (2011) Biomolecule profiles in inedible wild mushrooms with antioxidant value. Molecules 16:4328–4338
Reshetnikov SV, Wasser SP, Tan KK (2001) Higher Basidiomycota as a source of antitumor and immunostimulating polysaccharides. Int J Med Mushr 3:361–394
Riveline JP, Schaepelynck P, Chaillous L, Renard E, Sola-Gazagnes A et al (2012) Assessment of patient-led or physician-driven continuous glucose monitoring in patients with poorly controlled type 1 diabetes using basal-bolus insulin regimens. Diabetes Care 35:965–971
Romain AJ, Desplan M, Carayol M, Ninot G, Fedou C (2011) Effect of breakfast on the maximum lipid oxidation level in exercise. Diabetes Metab 37:A19
Romain AJ, Bernard P, Attalin V, Gernigon C, Ninot G, Avignon A (2012) Health-related quality of life and stages of behavior change for exercise in overweight/obese individuals. Diabetes Metab doi:10.1016/j.diabet.2012.03.003
Rosenbloom AL, Joe JR, Young RS, Winter WE (1999) Emerging epidemic of type 2 diabetes in youth. Diabetes Care 22:345–354
Rubel RL, Santa HSD, Fernandes LC, Bonatto SJR, Bello S et al (2011) Hypolipidemic and antioxidant properties of Ganoderma lucidum (Leyss:Fr) Karst used as a dietary supplement. World J Microbiol Biotechnol 27:1083–1089
Saltiel AR, Kahn CR (2001) Insulin signalling and the regulation of glucose and lipid metabolism. Nature 414:799–806
Sanodiya BS, Thakur GS, Baghel RK, Prasad GBKS, Bisen PS (2009) Ganoderma lucidum: a potent pharmacological macrofungus. Curr Pharmaceutical Biotechnol 10:717–742
Sato T, Tai Y, Nunoura Y, Yajima Y, Kawashima S, Tanaka K (2002) Dehydrotrametenolic acid induces preadipocyte differentiation and sensitizes animal models of noninsulin-dependent diabetes mellitus to insulin. Biol Pharm Bull 25:81–86
Sattar N (2012) Biomarkers for diabetes prediction, pathogenesis or pharmacotherapy guidance? Past, present and future possibilities. Diabetic Med 29:5–13
Scheen AJ (2011) Linagliptin for the treatment of type 2 diabetes (pharmacokinetic evaluation). Expert Opinion on drug metab Toxicol 7:1561–1576
Schneider KL, Pagoto SL, Handschin B, Panza E, Bakke S, Liu Q, Blendea M, Ockene IS, Ma Y (2011) Design and methods for a pilot randomized clinical trial involving exercise and behavioral activation to treat comorbid type 2 diabetes and major depressive disorder. Ment Health Phys Act 4:13–21
Seino S, Takahashi H, Takahashi T, Shibasaki T (2012) Treating diabetes today: a matter of selectivity of sulphonylureas. Diabetes Obes Metab 14:9–13
Seto SW, Lam TY, Tam HL, Au AL, Chan SW, Wu JH, Yu PH, Leung GP, Ngai SM, Yeung JH, Leung PS, Lee SM, Kwan YW (2009) Novel hypoglycemic effects of Ganoderma lucidum water-extract in obese/diabetic (+db/+db) mice. Phytomedicine 16:426–436
Shang D, Li Y, Wang C, Wang X, Yu Z, Fu X (2011) A novel polysaccharide from Se-enriched Ganoderma lucidum induces apoptosis of human breast cancer cells. Oncol Rep 25:267–272
Shavit E (2009) Over-the-Counter Medicinal Mushrooms. Fungi 2:15–19
Shaw JE, Sicree RA, Zimment PZ (2010) Global estimates of the prevalence of diabetes for 2110 and 2030. Diabetes Res Clin Pract 87:4–14
Shawahna R, Nisar-ur-Rahman N, Ahmad M, Debray M, Decleves X, Yliperttula M, Blom M (2012) Prescribers’ perspectives of the socioeconomic status and important indicators affecting prescribing behavior in a developing country. Central European J Med (CEJMed) 7:1–8
Shechter Y (1990) Insulin-mimetic effects of vanadate. Possible implications for future treatment of diabetes. Diabetes 39:1–5
Shi B, Wang Z, Jin H, Chen YW, Wang Q, Qian Y (2009) Immunoregulatory Cordyceps sinensis increases regulatory T cells to Th17 cell ratio and delays diabetes in NOD mice. Int Immunopharmacol 9:582–586
Shin S, Lee S, Kwon J, Moon S, Lee S, Lee CK, Cho K, Ha NJ, Kim K (2009) Cordycepin suppresses expression of diabetes regulating genes by inhibition of lipopolysaccharide-induced inflammation in macrophages. Immune Netw 9:98–105
Shu CH, Lin KJ, Wen BJ (2004) Effects of culture pH on the production of bioactive polysaccharides by Agaricus blazei in batch cultures. J Chem Technol Biotechnol 79:998–1002
Sliva D (2003) Ganoderma lucidum (Reishi) in cancer treatment. Integr Cancer Ther 2:358–364
Smiderle FR, Olsen LM, Ruthes AC, Czelusniak PA, Santana-Filho AP, Sassaki GL, Gorin PAJ, Iacomini M (2012) Exopolysaccharides, proteins and lipids in Pleurotus pulmonarius submerged culture using different carbon sources. Carbohyd Polym 87:368–376
Smith KJ, Pagé V, Gariépy G, Béland M, Badawi G, Schmitz N (2012) Self-rated diabetes control in a Canadian population with type 2 diabetes: associations with health behaviours and outcomes. Diabetes Res Clin Pract 95:162–168
Sobngwi E, Ndour-Mbaye M, Boateng KA, Ramaiya KL, Njenga EW, Diop SN, Mbanya JC, Ohwovoriole AE (2012) Type 2 diabetes control and complications in specialised diabetes care centres of six sub-Saharan African countries: The Diabcare Africa study. Diabetes Res Clin Pract 95:30–36
Song G, Du Q (2010) Isolation of a polysaccharide with anticancer activity from Auricularia polytricha using high-speed countercurrent chromatography with an aqueous two-phase system. J Chromatogr A 1217:5930–5934
Sorimachi K, Koge T (2008) Agaricus blazei water extracts as alternative medicines. Curr Pharm Anal 4:39–43
Stadler M, Pacini G, Petrie J, Luger A, Anderwald C, RISC Investigators (2009) Beta cell (dys)function in non-diabetic offspring of diabetic patients. Diabetologia 52:2435–2444
Stuart MJ, Baune BT (2012) Depression and type 2 diabetes: inflammatory mechanisms of a psychoneuroendocrine co-morbidity. Neurosci Biobehav Rev 36:658–676
Stumvoll M, Tataranni PA, Stefan N, Vozarova B, Bogardus C (2003) Glucose allostasis. Diabetes 52:903–909
Sun JE, Ao ZH, Lu ZM, Xu HY, Zhang XM, Dou WF, Xu ZH (2008) Antihyperglycemic and antilipidperoxidative effects of dry matter of culture broth of Inonotus obliquus in submerged culture on normal and alloxan-diabetes mice. J Ethnopharmacol 118:7–13
Sysouphanthong P, Thongkantha S, Zhao R, Soytong K, Hyde KD (2010) Mushroom diversity in sustainable shade tea forest and the effect of fire damage. Biodivers Conservation 19:1401–1415
Takeujchi H, He P, Mooi LY (2004) Reductive effect of hot-water extracts from woody ear (Auricularia auricula-judae Quél.) on food intake and blood glucose concentration in genetically diabetic KK-Ay mice. J Nutr Sci Vitaminol (Tokyo) 50(4):300–304
Talbot F, Nouwen A (2000) A review of the relationship between depression and diabetes in adults: is there a link? Diabetes Care 23:1556–1562
Taveira VC, Novaes MR, Dos Anjos RM, de Silva MF (2008) Hematologic and metabolic effects of dietary supplementation with Agaricus sylvaticus fungi on rats bearing solid walker 256 tumor. Exp Biol Med (Maywood) 233:1341–1347
Teng BS, Wang CD, Yang HJ, Wu JS, Zhang D, Zheng M, Fan ZH, Pan D, Zhou P (2011) A protein tyrosine phosphatase 1B activity inhibitor from the fruiting bodies of Ganoderma lucidum (Fr.) Karst and its hypoglycemic potency on streptozotocin-induced type 2 diabetic mice. J Agric Food Chem 59:6492–6500
Teng BS, Wang CD, Zhang D, Wu JS, Pan D, Pan LF, Yang HJ, Zhou P (2012) Hypoglycemic effect and mechanism of a proteoglycan from Ganoderma lucidum on streptozotocin-induced type 2 diabetic rats. Eur Rev Med Pharmacol Sci 16:166–175
Thielen V, Scheen A, Bringer J, Renard E (2010) Attempt to improve glucose control in type 2 diabetic patients by education about real-time glucose monitoring. Diabetes Metab 36:240–243
Thornalley PJ (2002) Glycation in diabetic neuropathy: Characteristics, consequences, causes, and therapeutic options. Int Rev Neurobiol 50:37–57
Thyagarajan-Sahu A, Lane B, Sliva D (2011) ReishiMax, mushroom based dietary supplement, inhibits adipocyte differentiation, stimulates glucose uptake and activates AMPK. BMC Complement Altern Med 11:74
Tie L, Yang HQ, An Y, Liu SQ, Han J, Xu Y, Hu M, Li WD, Chen AF, Lin ZB, Li XJ (2012) Ganoderma lucidum polysaccharide accelerates refractory wound healing by inhibition of mitochondrial oxidative stress in type 1 diabetes. Cell Physiol Biochem 29:583–594
Tourlouki E, Matalas AL, Panagiotakos DB (2009) Dietary habits and cardiovascular disease risk in middle-aged and elderly populations: a review of evidence. Clin Interv Aging 4:319–330
Ulziijargal E, Mau JL (2011) Nutrient compositions of culinary-medicinal mushroom fruiting bodies and mycelia. Int J Med Mushr 13:343–349
Vinicor F (1998) The public health burden of diabetes and the reality of the limits. Diabetes Care 21:C15–C18
Volman JJ, Mensink RP, van Griensven LJ, Plat J (2010) Effects of alpha-glucans from Agaricus bisporus on ex vivo cytokine production by LPS and PHA-stimulated PBMCs; a placebo-controlled study in slightly hypercholesterolemic subjects. Eur J Clin Nutr 64:720–726
Wachtel-Galor S, Tomlinson B, Benzie FF (2004) Ganoderma lucidum (‘Lingzhi’), a Chinese medicinal mushroom: biomarker responses in a controlled human supplementation study. Br J Nutr 91:263–269
Wang JCY, Hu SH, Wang JT, Chen KS, Chia YC (2005) Hypoglycemic effect of extract of Hericium erinaceus. J Sci Food Agr 85:641–646
Wang W, Fu C, Pan C, Chen W, Zhan S, Luan R et al (2009a) How do Type 2 diabetes mellitus-related chronic complications impact direct medical cost in four major cities of urban China? Value Health 12:923–929
Wang W, McGreevey WP, Fu C, Zhan S, Luan R, Chen W, Xu B (2009b) Type 2 diabetes mellitus in China: a preventable economic burden. Am J Manag Care 15:593–601
Wang S, Meckling KA, Marcone MF, Kakuda Y, Tsao R (2011a) Can phytochemical antioxidant rich foods act as anti-cancer agents? Food Res Int 44:2545–2554
Wang CR, Ng TB, Li L, Fang JC, Jiang Y, Wen TY, Qiao WT, Li N, Liu F (2011b) Isolation of a polysaccharide with antiproliferative, hypoglycemic, antioxidant and HIV-1 reverse transcriptase inhibitory activities from the fruiting bodies of the abalone mushroom Pleurotus abalones. J Pharm Pharmacol 63:825–832
Wang CD, Teng BS, He YM, Wu JS, Pan D, Pan LF, Zhang D, Fan ZH, Yang HJ, Zhou P (2012) Effect of a novel proteoglycan PTP1B inhibitor from Ganoderma lucidum on the amelioration of hyperglycaemia and dyslipidaemia in db/db mice. British J Nutrition doi: 10.1017/S0007114512000153
Wani BA, Bodha RH, Wani AH (2010) Nutritional and medicinal importance of mushrooms. J Med Plants Res 4:2598–2604
Wasser SP (2011) Current findings, future trends, and unsolved problems in studies of medicinal mushrooms. Appl Microbiol Biotechnol 89:1323–1332
Wasser SP, Akavia E (2008) Regulatory issues of mushrooms as functional foods and dietary supplements: safety and efficacy. In: Cheung PCK (ed) Mushrooms as functional foods. Wiley, New York, pp 199–221
Wasser SP, Weiss AL (1999) Therapeutic effects of substances occurring in higher Basidiomycetes mushrooms: a modern perspective. Crit Rev Immunol 19:65–96
Welti S, Courtecuisse R (2010) The Ganodermataceae in the French West Indies (Guadeloupe and Martinique). Fungal Divers 43:103–126
Weng CJ, Yen GC (2010) The in vitro and in vivo experimental evidences disclose the chemopreventive effects of Ganoderma lucidum on cancer invasion and metastasis. Clin Exp Metastasis 27:361–369
White NH, Sun W, Cleary PA, Danis RP, Davis MD, Hainsworth DP, Hubbard LD, Lachin JM, Nathan DM (2008) Prolonged effect of intensive therapy on the risk of retinopathy complications in patients with type 1 diabetes mellitus: 10 years after the Diabetes Control and Complications Trial. Arch Ophthalmol 126:1707–1715
WHO (2011) World Health Organization. Diabetes program http://www.who.int/mediacentre/factsheets/fs312/en/
Wild S, Roglic F, Green A, Sucree R, King H (2004) Global prevalence of diabetes: estimated for the year 2000 and projections for 2030. Diabetes Care 27:1047–1053
Winkley K, Sallis H, Kariyawasam D, Leelarathna LH, Chalder T, Edmonds ME, Stahl D, Ismail K (2012) Five-year follow-up of a cohort of people with their first diabetic foot ulcer: the persistent effect of depression on mortality. Diabetologia 55:303–310
Wisitrassameewong K, Karunarathna SC, Thongklang N, Zhao R, Callac P, Moukha S, Férandon C, Chukeatirote E, Hyde KD (2012) Agaricus subrufescens: a review. Saudi J Biol Sci 19:131–146
Wolden-Kirk H, Overbergh L, Christesen HT, Brusgaard K, Mathieu C (2011) Vitamin D and diabetes: its importance for beta cell and immune function. Mol Cell Endocrinol 347:106–120
Won SY, Park EH (2005) Anti-inflammatory and related pharmacological activities of cultured mycelia and fruiting bodies of Cordyceps militaris. J Ethnopharmacol 96:555–561
Wong KH, Vikineswary S, Noorlidah A, Umah RK, Murali N (2009) Effects of cultivation techniques and processing on antimicrobial and antioxidant activities of Hericium erinaceus (Bull. :Fr.) Pers. Extracts. Food Technol Biotechnol 47:47–55
Wong YY, Moon A, Duffin R, Barateig AB, Meijer HA, Clemens MJ, de Moor CH (2010) Cordycepin inhibits protein synthesis and cell adhesion through effects on signal transduction. J Biol Chem 285:2610–2621
Wu D, Pae M, Ren Z, Guo Z, Smith D, Meydani SN (2007) Dietary supplementation with white button mushroom enhances natural killer cell activity in C57BL/6 mice. J Nutr 137:1472–1477
Wu SH, Nilsson HR, Chen CT, Yu SY, Hallenberg N (2010) The white-rotting genus Phanerochaete is polyphyletic and distributed throughout the phleboid clade of the Polyporales (Basidiomycota). Fungal Divers 42:107–118
Wu GS, Lu JJ, Guo JJ, Li YB, Tan W, Dang YY, Zhong ZF, Xu ZT, Chen XP, Yi-Tao Wang YT (2012) Ganoderic acid DM, a natural triterpenoid, induces DNA damage, G1 cell cycle arrest and apoptosis in human breast cancer cells. Fitoterapia 83:408–414
Xiao C, Wu QP, Tan JB, Cai W, Yang XB, Zhang JM (2011) Inhibitory effects on alpha-glucosidase and hypoglycemic effects of the crude polysaccharides isolated from 11 edible fungi. J Med Plants Res 5:6963–6967
Xie W, Du L (2011) Diabetes is an inflammatory disease: evidence from traditional Chinese medicines. Diabetes Obes Metab 13:289–301
Xin X, Chong P, Chengjian Y, Yitong Z, Hongyu X, Zhenming L, Zhenghong X (2010) Antihyperglycemic and antilipidperoxidative effects of polysaccharides extracted from medicinal mushroom Chaga, Inonotus obliquus (Pers.: Fr.) Pilat (Aphyllophoromycetideae) on alloxan-diabetes mice. Int J Med Mushr 12:235–244
Xu X, Pang C, Yang C, Zheng Y, Xu H, Lu Z, Xu Z (2010a) Antihyperglycemic and antilipidperoxidative effects of polysaccharides extracted from medicinal mushroom Chaga, Inonotus obliquus (Pers.: Fr.) Pilat (Aphyllophoromycetideae) on alloxan-diabetes mice. Int J Med Mushr 12:235–244
Xu HY, Sun JE, Lu ZM, Zhang XM, Dou WF, Xu ZH (2010b) Beneficial effects of the ethanol extract from the dry matter of a culture broth of Inonotus obliquus in submerged culture on the antioxidant defence system and regeneration of pancreatic beta-cells in experimental diabetes in mice. Nat Prod Res 24:542–553
Xu X, Wu Y, Chen H (2011) Comparative antioxidative characteristics of polysaccharide-enriched extracts from natural sclerotia and cultured mycelia in submerged fermentation of Inonotus obliquus. Food Chem 127:74–79
Yamac M, Kanbak G, Zeytinoglu M, Bayramoglu G, Senturk H, Uyanoglu M (2008) Hypoglycemic effect of Lentinus strigosus (Schwein.) Fr. crude exopolysaccharide in streptozotocin-induced diabetic rats. J Med Food 11:513–517
Yamac M, Zeytinoglu M, Kanbak G, Bayramoglu G, Senturk H (2009) Hypoglycemic effect of crude exopolysaccharides produced by Cerrena unicolor, Coprinus comatus, and Lenzites betulina isolates in streptozotocin-induced diabetic rats. Pharm Biol 47:168–174
Yamac M, Kanbak G, Zeytinoglu M, Senturk H, Bayramoglu G, Dokumacioglu A, Van Griensven LJLD (2010) Pancreas protective effect of button mushroom Agaricus bisporus (J.E. Lange) Imbach (Agaricomycetidae) extract on rats with streptozotocin-induced diabetes. Int J Med Mushr 124:379–389
Yamamoto K, Kimura T (2010) Dietary Sparassis crispa (Hanabiratake) ameliorates plasma levels of adiponectin and glucose in type 2 diabetic mice. J Health Sci 56:541–546
Yang ZL (2011) Molecular techniques revolutionize knowledge of basidiomycete evolution. Fungal Divers 50:47–58
Yang BK, Kim DH, Jeong SC, Das S, Choi YS, Shin JS, Lee SC, Song CH (2002) Hypoglycemic effect of a Lentinus edodes exo-polymer produced from a submerged mycelial culture. Biosci Biotechnol Biochem 66:937–942
Yang BK, Kim GN, Jeong YT, Jeong H, Mehta P, Song CH (2008) Hypoglycemic effects of exo-biopolymers produced by five different medicinal mushrooms in STZ-induced diabetic rats. Mycobiol 36:45–49
Yates T, Khunti K, Wilmot EG, Brady E, Webb D, Srinivasan B, Henson J, Talbot D, Davies MJ (2012) Self-reported sitting time and markers of inflammation, insulin resistance, and adiposity. Am J Prev Med 42:1–7
Ye LB, Zheng X, Zhang J, Tang Q, Yang Y, Wang X, Li J, Liu YF, Pan YJ (2011) Biochemical characterization of a proteoglycan complex from an edible mushroom Ganoderma lucidum fruiting bodies and its immunoregulatory activity. Food Res Int 44:367–372
Yeh GY, Eisenberg DM, Kaptchuk TJ, Phillips RS (2003) Systematic review of herbs and dietary supplements for glycemic control in diabetes. Diabetes Care 26:1277–1294
Ying J, Mao X, Ma Q, Zong Y, Wen H (1987) Icons of Medicinal Fungi from China (translated, Yuehan X). Science Press, Beijing
Yoo O, Lee DH (2006) Inhibition of sodium glucose cotransporter-1 expressed in Xenopus laevis oocytes by 4-acetoxyscirpendiol from Cordyceps takaomantana (anamorph = Paecilomyces tenuipes). Med Mycol l44:79–85
Yoo O, Son JH, Lee DH (2005) 4-Acetoxyscirpendiol of Paecilomyces tenuipes inhibits Na(+)/D-Glucose cotransporter expressed in Xenopus laevis oocytes. J Biochem Mol Biol 38:211–217
Yu R, Song L, Zhao Y, Bin W, Wang L, Zhang H, Wu Y, Ye W, Yao X (2004) Isolation and biological properties of polysaccharide CPS-1 from cultured Cordyceps militaris. Fitoterapia 75:465–472
Yu R, Yang W, Song L, Yan C, Zhang Z, Zhao Y (2007) Structural characterization and antioxidant activity of a polysaccharide from the fruiting bodies of cultured Cordyceps militaris. Carbohyd Polym 70:430–436
Yu J, Cui PJ, Zeng WL, Xie XL, Liang WJ, Lin GB, Zeng L (2009) Protective effect of selenium-polysaccharides from the mycelia of Coprinus comatus on alloxan-induced oxidative stress in mice. Food Chem 117:42–47
Yu T, Shim J, Yang Y, Byeon SE, Kim JH, Rho HS, Park H, Sung GH, Kim TW, Rhee MH, Cho JY (2012) 3-(4-(tert-Octyl)phenoxy)propane-1,2-diol suppresses inflammatory responses via inhibition of multiple kinases. Biochem Pharmacol 83:1540–1551
Yuan Z, He P, Cui J, Takeuchi H (1998) Hypoglycemic effect of water-soluble polysaccharide from Auricularia auricula-judae Quél. on genetically diabetic KK-Ay mice. Biosci Biotechnol Biochem 62:1898–1903
Yun YH, Han SH, Lee SJ, Ko SK, Lee CK, Ha NJ, Kim KJ (2003) Anti-diabetic effects of CCCA, CMKSS and Cordycepin from Cordyceps militaris and the immune responses in streptozotocin-induced diabetic mice. Nat Prod Sci 9:291–298
Zaidman BZ, Wasser SP, Nevo E, Mahajna J (2008) Coprinus comatus and Ganoderma lucidum interfere with androgen receptor function in LNCaP prostate cancer cells. Mol Biol Rep 35:107–117